Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
NN Inc
NNBR
$257M
| $410K | ﹤0.01% |
136,702
+108,301
| +381% | +$379K |
|
3277
Townsquare Media
TSQ
$102M
| $410K | ﹤0.01% |
37,411
+4,353
| +13% | +$50.2K |
|
|
ADVM
3278
DELISTED
Adverum Biotechnologies
ADVM
| $410K | ﹤0.01% |
59,734
+49,021
| +458% | +$456K |
|
3279
USCB Financial Holdings
USCB
$403M
| $408K | ﹤0.01% |
31,831
+2,353
| +8% | +$27.4K |
|
|
ZYXI
3280
DELISTED
Zynex
ZYXI
| $407K | ﹤0.01% |
43,656
-5,978
| -12% | -$63.6K |
|
|
ESSA
3281
DELISTED
ESSA Bancorp
ESSA
| $405K | ﹤0.01% |
23,046
| – | – |
|
3282
Crawford & Co Class A
CRD.A
$532M
| $404K | ﹤0.01% |
46,815
+3,477
| +8% | +$32.2K |
|
3283
Babcock & Wilcox
BW
$1.41B
| $400K | ﹤0.01% |
275,735
-138,292
| -33% | -$166K |
|
3284
Wheels Up
UP
$217M
| $399K | ﹤0.01% |
+10,562
| New | +$506K |
|
3285
Invesco Dividend Achievers ETF
PFM
$792M
| $395K | ﹤0.01% |
9,261
-797
| -8% | -$33.5K |
|
3286
Concrete Pumping Holdings
BBCP
$496M
| $395K | ﹤0.01% |
65,736
+784
| +1% | +$5.41K |
|
3287
Paysign
PAYS
$512M
| $395K | ﹤0.01% |
91,615
+7,444
| +9% | +$32.8K |
|
3288
Foghorn Therapeutics
FHTX
$278M
| $394K | ﹤0.01% |
68,495
+13,053
| +24% | +$77.8K |
|
3289
Ispire Technology
ISPR
$82.7M
| $392K | ﹤0.01% |
49,003
+8,094
| +20% | +$52.2K |
|
3290
InfuSystem Holdings
INFU
$185M
| $392K | ﹤0.01% |
57,378
+5,207
| +10% | +$38.3K |
|
3291
Medallion Financial
MFIN
$233M
| $390K | ﹤0.01% |
+50,765
| New | +$402K |
|
3292
Silvercrest Asset Management
SAMG
$76.1M
| $389K | ﹤0.01% |
24,977
| – | – |
|
3293
Investar Holding Corp
ISTR
$411M
| $386K | ﹤0.01% |
+25,072
| New | +$396K |
|
3294
Cadiz
CDZI
$264M
| $386K | ﹤0.01% |
124,857
+9,275
| +8% | +$25.2K |
|
3295
Future Fuel
FF
$218M
| $384K | ﹤0.01% |
74,814
+5,649
| +8% | +$30.5K |
|
|
NAGE
3296
Niagen Bioscience
NAGE
$264M
| $383K | ﹤0.01% |
140,169
+115,502
| +468% | +$386K |
|
3297
Entravision Communication
EVC
$1.07B
| $382K | ﹤0.01% |
188,166
-43,508
| -19% | -$90.1K |
|
3298
Seres Therapeutics
MCRB
$46.3M
| $381K | ﹤0.01% |
26,297
-11,069
| -30% | -$185K |
|
3299
Fresenius Medical Care
FMS
$13.8B
| $380K | ﹤0.01% |
19,928
+8,171
| +69% | +$167K |
|
3300
Inhibrx
INBX
$1.24B
| $379K | ﹤0.01% |
+26,772
| New | +$418K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.